BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 23, 2008
View Archived Issues
$125M Deal Sends Mirus Bio Into the Roche RNAi Camp
Roche Holding AG, fresh off its $44 billion offer for Genentech Inc., moved to accelerate its research into RNAi gene silencing technology with the acquisition of Mirus Bio Corp. for $125 million. (BioWorld Today)
Read More
BioMarin, Summit Partner for Duchenne Drug in $143M Deal
Read More
Biogen's Strong 2nd Quarter Helped by Tysabri Sales
Read More
Depomed Gets $12M Up Front in Diabetes Deal with Santarus
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More
Financings Roundup
Read More